Educational Nudge Intervention for Overmedication in People Living With Dementia

Recruiting in Palo Alto (17 mi)

+1 other location

Overseen byDonovan Maust, MD, MS

Age: 18+

Sex: Any

Travel: May Be Covered

Time Reimbursement: Varies

Trial Phase: Academic

Waitlist Available

Sponsor: University of Michigan

No Placebo Group

Trial Summary

What is the purpose of this trial?The goal of this project is to address Central nervous system-active polypharmacy (CNS polyRx) in people with living dementia (PLWD) through focus group and an educational intervention. This project involves three interconnected Aims and includes engaging clinicians, patients/PLWD, and care partners (CP). AIM 1 will be completed for the development of the educational tool and is not considered a clinical trial. Therefore, this registration includes the clinical trial (Aims 2 and 3) of the project. The study hypothesizes that the total standardized daily dosage (TSDD) of the medication classes contributing to CNS polyRx will decline from baseline to 4 months in participants receiving the nudge intervention.

Eligibility Criteria

This trial is for people with dementia or mild cognitive impairment who are being treated at selected Michigan Medicine and Henry Ford Health System clinics. Participants must be taking three or more medications that affect the central nervous system, like antidepressants or opioids.

Inclusion Criteria

You are taking three or more certain types of medications that affect the central nervous system such as antidepressants, antipsychotics, or opioids.

You are getting medical care at specific primary care clinics at Michigan Medicine and Henry Ford Health System.

You have been diagnosed with dementia or mild cognitive impairment.

Exclusion Criteria

Primary care clinicians review of participants and determines intervention is not appropriate

Participant Groups

The study tests an educational 'nudge' designed to reduce the use of multiple mind-affecting drugs in those living with dementia. It aims to lower the total daily dosage of these medications over a four-month period.

2Treatment groups

Experimental Treatment

Active Control

Group I: Educational nudge interventionExperimental Treatment1 Intervention

Participants will be mailed the educational tool in the form of a brochure.

Group II: No educational toolActive Control1 Intervention

This arm will collect data on total standardized daily dosage of the medication classes contributing to CNS polyRx from the Electronic Medical Record (EMR).